A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs

Completed

Conditions studied: Open-angle Glaucoma, Ocular Hypertension

In brief

The objective of the study was to evaluate whether timolol hemihydrate is more comfortable upon instillation than timolol maleate in sorbate. This was an observational study. Subjects with open-angle glaucoma or ocular hypertension were asked to complete a survey regarding their normal treatment. No treatment was prescribed.

Key facts

Study ID

NCT00823043

Run by

Vistakon Pharmaceuticals

People needed

103

Starts

2009-01-01

Expected to finish

2009-07-01

Last updated by the study team

2015-03-06

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• willing to comply with investigator's and protocol's instructions
• patients signature on the informed consent document
• open-angle glaucoma or ocular hypertension
• currently prescribed timolol hemihydrate (once a day (QD) or twice a day (BID))or timolol maleate in sorbate QD as monotherapy or as a part of 2-drug therapy in at least one eye

You may not qualify if…

• inability to understand the trial procedures
• inability to give informed consent
• inability to understand, read, or write English
• best corrected visual acuity of 20/200 or worse in each eye
• current moderate to severe infectious or inflammatory condition of the eye or eyelids including
• current moderate to severe dry eye syndrome
• current chronic use of ocular corticosteroids, ocular surgery or intraocular laser surgery to either eye in the prior 3 months
• treated with 3 or more glaucoma medicines in both eye

Where it is running

• Eye Care of San Diego — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.